Our Team

Board of Directors

Rick Doblin, Ph.D., Founder and President

Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Meet Rick

David Bronner, Board of Directors

Independent Voting Member David Bronner is Cosmic Engagement Officer (CEO) of Dr. Bronner’s, the top-selling brand of natural soaps in North America and producer of a range of organic body care and food products. He is a grandson of company founder, Emanuel Bronner, and a fifth-generation soapmaker. David and Michael established Dr. Bronner’s as a…
Meet David

Staff

Rick Doblin, Ph.D., Founder and President

Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Meet Rick

Kris Lotlikar, Executive Director

Kris Lotlikar serves as the Executive Director of MAPS, overseeing financing and strategic direction of MAPS’ organizations globally. Since joining the MAPS, Kris helped shepherd MAPS Public Benefit Corporation into the leading psychedelic drug development company, raising over $100 million for MAPS and MAPS PBC. Kris’s passion and expertise is in building high-performing organizations in…
Meet Kris

Fede Menapace, Deputy Director

Fede serves as the Deputy Director for the Multidisciplinary Association for Psychedelic Studies (MAPS) where he oversees day-to-day operations and supports the MAPS team in developing and achieving our strategic priorities. Fede also helps guide MAPS subsidiaries on governance and financing matters. Born and raised in the Trentino region in northern Italy, he began his…
Meet Fede

MAPS Public Benefit Corporation (MAPS PBC)

MAPS Public Benefit Corporation (MAPS PBC) is a Delaware public benefit corporation and a wholly owned subsidiary of MAPS with the special purpose to balance income from legal sales of MDMA with the social benefits of MAPS’ mission.

Board of Directors: MAPS Public Benefit Corporation (MAPS PBC)

Rick Doblin, Ph.D., Founder and President

Rick Doblin, Ph.D., is the Founder and President of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs.…
Meet Rick

Staff: MAPS Public Benefit Corporation (MAPS PBC)

Michael Mullette, Chief Operating Officer (MAPS PBC)

Michael Mullette is an experienced drug development and commercialization expert, currently serving as Chief Operating Officer at MAPS Public Benefit Corporation (MAPS PBC). Mullette most recently served as the Vice President and Managing Director of North America for Moderna, where he oversaw commercialization of the company’s COVID-19 vaccine during the height of the pandemic. 
Meet Michael

Berra Yazar-Klosinski, Ph.D., Chief Scientific Officer of the MAPS Public Benefit Corporation

Berra Yazar-Klosinski, Ph.D., is Chief Scientific Officer of the MAPS Public Benefit Corporation (MAPS PBC). Dr. Yazar-Klosinski is responsible for development of strategic, catalytic, and capacity-building activities to facilitate research on the risk/benefit profile of psychedelics in compliance with the global regulatory landscape. She has been actively involved in the various stages of nonclinical and…
Meet Berra